To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Adderall (Amphetamine Mixed Salts) XR for Attention Deficit/Hyperactivity Disorder Launched in United States URL: http://www.pslgroup.com/dg/20C0CA.htm Doctor's Guide October 29, 2001
BASINGSTOKE, ENGLAND -- October 29, 2001 -- Shire Pharmaceuticals Group plc today presented its new once a day treatment for attention deficit/hyperactivity disorder (ADHD) Adderall (amphetamine mixed salts) XR to its sales force in the United States. Adderall XR, a novel formulation of Shire's U.S. ADHD brand leader Adderall (1,2,3), is designed to provide an all day treatment with one morning dose. This is considered to be an increasingly important benefit for children with ADHD and their caregivers, both at home and at school.
References:
1. Side effects: Loss of appetite, insomnia, stomach aches and emotional liability.
2. Manos MJ, Short EJ, Findling RL. Differential Effectiveness of Methylphenidate and Adderall® in School-Age Youths with Attention Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 1999;38(7):1-7.
3. Pelham WE, Aronoff HR, Midlam JK, et al. A Comparison of Ritalin and Adderall: Efficacy and Time-course in Children with Attention-deficit/Hyperactivity Disorder. Pediatrics. 1999;103:1-14.
4. Swanson JM, Wigal S, Greenhill LL, Browne R, et al. Analog Classroom Assessment of Adderall in Children with ADHD. J Am Acad Child Adolesc Psychiatry. 1998;37:519-526.
SOURCE: Shire Pharmaceuticals
Related Link: Adderall (amphetamine mixed salts). --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.